Neuroblastoma: all 634 studies
Page 5 of 7. Open to participants first (122), then studies with results posted, then the rest; newest registration first within each.
- Studying Biomarkers in Samples From Patients With High-Risk NeuroblastomaCompletedNCT01510600
- Biomarkers in Tumor Samples From Younger Patients With NeuroblastomaCompletedNCT01493830
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical ImagingCompletedNCT01482741
- Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaCompletedNCT01467986Phase 2
- Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related DonorsCompletedNCT01462396Phase 1
- Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNCT01445379Phase 1
- Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive TumorsCompletedNCT01419834Phase 1
- Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk NeuroblastomaCompletedNCT01418495
- Protein Expression in Human Neuroblastoma Tumor SamplesCompletedNCT01407731
- Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric NeuroblastomaTerminatedNCT01404702Phase 1
- Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed NeuroblastomaCompletedNCT01387724
- NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT01386619Phase 1/2
- 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsStatus unknownNCT01373736Phase 3
- Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With NeuroblastomaCompletedNCT01358617
- Biomarkers in Samples From Young Patients With NeuroblastomaCompletedNCT01358604
- Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing CancerCompletedNCT01353300
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Aflac ST1001 Prolonged IsotretinoinWithdrawnNCT01319838Phase 1
- Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)Status unknownNCT01308905Not applicable
- Immunomonitoring of Children With NeuroblastomaStatus unknownNCT01295762Not applicable
- A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCompletedNCT01288573Phase 1/2
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and SarcomaCompletedNCT01241162Phase 1
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerCompletedNCT01222780Phase 1
- Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaCompletedNCT01208454Phase 1
- Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaActive, not recruitingNCT01192555Phase 1/2
- New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWithdrawnNCT01174537Phase 1/2
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsCompletedNCT01169584Phase 1
- Biomarkers in Young Patients With NeuroblastomaCompletedNCT01169376
- Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With NeuroblastomaStatus unknownNCT01156350Phase 2
- A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and LymphomasCompletedNCT01132911Phase 1
- A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWithdrawnNCT01130623Phase 1
- The Role of IMP3 Expression in Patients With NeuroblastomaCompletedNCT01121419
- Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])CompletedNCT01119560
- A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent NeuroblastomaCompletedNCT01109238
- Pharmacokinetic Study of Doxorubicin in Children With CancerCompletedNCT01095926Phase 2
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNCT01077440
- The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN ExpressionCompletedNCT01075360
- The Role of Glycosyltransferases in the Oncogenesis of NeuroblastomaCompletedNCT01058798
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedNCT01048892Phase 1
- 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)WithdrawnNCT01048086Phase 2
- N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed NeuroblastomaCompletedNCT01019850Phase 1
- Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
- Efficacy and Safety of Ultratrace™ Iobenguane I 131 in NeuroblastomaWithdrawnNCT00992173Phase 2
- A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma PatientsTerminatedNCT00969722Phase 2
- Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic NeuroblastomaCompletedNCT00960739Phase 2
- Study of Specimens From Young Patients With NeuroblastomaCompletedNCT00958659
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
- A Vaccine Study for High Risk CancersWithdrawnNCT00944580Phase 1
- Isotretinoin in Treating Young Patients With High-Risk NeuroblastomaStatus unknownNCT00939965Not applicable
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsCompletedNCT00931931Phase 1
- Informed Consent in Pediatric Cancer TrialsCompletedNCT00923650
- Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid TumoursCompletedNCT00918320Phase 2
- Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk NeuroblastomaCompletedNCT00911560Phase 1/2
- Studying Tumor Samples From Young Patients With NeuroblastomaCompletedNCT00907920
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or GanglioneuroblastomaCompletedNCT00904241
- Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantCompletedNCT00900406
- Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
- Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
- Study of DNA in Blood Samples From Patients With NeuroblastomaCompletedNCT00898391
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00885326Phase 1
- Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk NeuroblastomaCompletedNCT00877110Phase 1
- Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.WithdrawnNCT00874315Phase 2
- Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
- Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesTerminatedNCT00813501
- Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsCompletedNCT00799461Phase 3
- 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk NeuroblastomaStatus unknownNCT00798148Phase 1/2
- Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk NeuroblastomaCompletedNCT00793845Phase 2
- Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous TransplantationCompletedNCT00793351Phase 2
- Haploidentical Stem Cell Transplantation in NeuroblastomaStatus unknownNCT00790413Early Phase 1
- A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesCompletedNCT00782145Phase 3
- A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With CancerCompletedNCT00754286Not applicable
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and MelanomaCompletedNCT00743496Phase 1
- Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected NeuroblastomaApproved for marketingNCT00730444
- The Effectiveness of the Neutropenic Diet in Pediatric Oncology PatientsCompletedNCT00726934Not applicable
- A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor CellsCompletedNCT00703222Phase 1/2
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked ProductsCompletedNCT00695279
- Autologous Transplant Followed by Allogeneic Transplant for High Risk NeuroblastomaTerminatedNCT00670410Phase 1
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00646230Phase 1
- Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaCompletedNCT00644696Phase 1
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid TumorsWithdrawnNCT00624962Not applicable
- Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersCompletedNCT00608452
- I-123-MIBG for Imaging of Neuroblastoma and PheochromocytomaCompletedNCT00590096
- ZD6474 Alone and in Combination With Retinoic Acid in Pediatric NeuroblastomaTerminatedNCT00533169Phase 1
- Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk NeuroblastomaStatus unknownNCT00526318Not applicable
- N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk NeuroblastomaCompletedNCT00509353Phase 1
- Enzastaurin in Treating Young Patients With Refractory Primary CNS TumorsCompletedNCT00503724Phase 1
- Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic NeuroblastomaCompletedNCT00492167Phase 1
- Safety Study of Nifurtimox for Relapsed or Refractory NeuroblastomaCompletedNCT00486564Phase 1
- Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk NeuroblastomaCompletedNCT00471679Phase 1
- Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory NeuroblastomaCompletedNCT00450827Phase 1
- Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed NeuroblastomaCompletedNCT00450307Phase 1
- Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal ImagingCompletedNCT00445718
- Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous ConditionsCompletedNCT00436696
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell TransplantStatus unknownNCT00417053Phase 3